Owlet Launches Medically-Certified Dream Sock In The UK And Across Europe
$OWLT
Industrial Machinery/Components
Industrials
Owlet Launches Medically-Certified Dream Sock In The UK And Across Europe
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/6/2021 | $12.00 → $5.00 | Neutral | Citigroup |
| 10/5/2021 | $8.50 → $5.50 | Buy → Neutral | BofA Securities |
| 9/8/2021 | $8.50 | Buy | BofA Securities |
| 8/5/2021 | $11.00 | Neutral | Citigroup |
10-Q - Owlet, Inc. (0001816708) (Filer)
8-K - Owlet, Inc. (0001816708) (Filer)
8-K - Owlet, Inc. (0001816708) (Filer)
Owlet (NYSE:OWLT) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.14) by 178.57 percent. The company reported quarterly sales of $14.800 million which missed the analyst consensus estimate of $16.430 million by 9.92 percent. This is a 38.32 percent increase over sales of $10.700 million the same period last year.
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the third quarter ended September 30, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business update today, November 13, 2024, at 4:30 p.m. ET. Q3 2024 Financial Highlights: Q3 Revenue of $22.1 million, up 141% from Q3 2023 Q3 Gross Margin of 52.2%, up 1,590 basis points from Q3 2023 Q3 Net Loss of $(5.6) million, compared to $(5.6) million in Q3 2023 Q3
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, announced today the participation in two upcoming investor conferences. Information on the conferences can be found below. Sidoti Micro Cap Conference BTIG Digital Health Forum Sidoti Micro Cap Conference Owlet will participate in the Sidoti Micro Cap Conference, being held virtually on Thursday, November 14, 2024. Kurt Workman, Owlet's Chief Executive Officer and Co-Founder, and Amanda Twede Crawford, Chief Financial Officer, are scheduled to present at 12:15 p.m. ET. In conjunction with the event, Owlet executives will also be available to participate in one-on-one meetings with investors re
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, plans to announce third quarter 2024 financial results after market close on Wednesday, November 13, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic) or 404-975-4839 (international) and reference Access Code 626609. A simultaneous webcast may be accessed online at the Events section of Owlet's Investor Rela
SC 13G/A - Owlet, Inc. (0001816708) (Subject)
SC 13D/A - Owlet, Inc. (0001816708) (Subject)
SC 13D/A - Owlet, Inc. (0001816708) (Subject)
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, is on a mission to raise critical funds for research that could bring an end to sudden infant death syndrome (SIDS). Owlet is partnering in this effort with Dr. Carmel Harrington, Honorary Research Fellow at Sydney Children's Hospital Westmead, and Elisha Palmer of Knox Blocks Foundation, both of whom are parents that have lost a child to SIDS. Sudden unexpected infant death (SUID), which includes SIDS, claims the lives of more than 3,000 babies each year in the U.S. alone1. The rate of SIDS is on the rise in the U.S.2 – making it one of the leading causes of infant mortality3. Despite this, there is m
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, today announces the appointment of Marc Stoll to the Company's Board of Directors. Stoll is currently an Investment Partner at Eclipse, a strategic investment firm focused on advancing the Industrial Evolution. His experience spans more than 25 years across the global finance and technology industries, and his expertise in leading corporate strategy and operational excellence will help bolster Owlet's future ventures and growth potential. "I'm thrilled to join Owlet's Board of Directors after spending time becoming very familiar with the brand and products, its life-changing mission and amazing custome
Owlet, Inc. (NYSE:OWLT, "the Company"))), the pioneer of smart baby monitoring, is pleased to announce the addition of Melissa Gonzales to the Company's Board of Directors. Gonzales brings more than 20 years of consumer and provider healthcare experience to Owlet, further advancing the Company as a leader in infant monitoring solutions. "Owlet's growth proposition to facilitate change in health equity through its innovation in connected digital monitoring is extremely exciting," said Melissa Gonzales. "Creating meaningful momentum and impact within these trends is important to me personally and professionally and I am looking forward to contributing my experience towards supporting Owlet'
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the third quarter ended September 30, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business update today, November 13, 2024, at 4:30 p.m. ET. Q3 2024 Financial Highlights: Q3 Revenue of $22.1 million, up 141% from Q3 2023 Q3 Gross Margin of 52.2%, up 1,590 basis points from Q3 2023 Q3 Net Loss of $(5.6) million, compared to $(5.6) million in Q3 2023 Q3
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, plans to announce third quarter 2024 financial results after market close on Wednesday, November 13, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic) or 404-975-4839 (international) and reference Access Code 626609. A simultaneous webcast may be accessed online at the Events section of Owlet's Investor Rela
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the second quarter ended June 30, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business update today, August 12, 2024, at 4:30 p.m. ET. Q2 2024 Financial Highlights: Obtained CE Medical certification for UK and Europe, launching Dream Sock across major European markets. Q2 Revenue was approximately $20.7 million, up approximately 58% year over year. Q2 Gr
Citigroup reiterated coverage of Owlet with a rating of Neutral and set a new price target of $5.00 from $12.00 previously
BofA Securities downgraded Owlet from Buy to Neutral and set a new price target of $5.50 from $8.50 previously
BofA Securities initiated coverage of Owlet with a rating of Buy and set a new price target of $8.50